Countdown to the Event
- 00Days
- 00Hrs
- 00Mins
- 00Secs
2-4 December 2024
Convention Centre DublinDublin, Ireland Mikko Turunen, PhDFounder and CSO at RNatives Inc.Speaker
Profile
Mikko Turunen, PhD, Adjunct Professor of Molecular Medicine at the University of Eastern Finland, has +27 years of experience in the development of gene therapies. Throughout his career, his research focus has been non-coding RNAs, cardiovascular disease, and gene delivery to animals. He was the first to show transcriptional gene activation by small RNAs in vivo (2009).
Agenda Sessions
Nuclear microRNA gene therapy: Use of AI-assisted discovery platform for transcriptional regulation
, 12:00View SessionPaving the Path for Innovation: Success Factors for Novel Gene Therapies
, 12:30View SessionChairperson's Opening Remarks
, 08:55View Session